|
FDA Approves Merilog, the First Rapid-Acting Insulin Biosimilar
|
Written by: J. Smith |
Hits: 1096
|
|
FDA Declares Semaglutide Shortage Resolved, Raising Concerns Over Compounded Versions
|
Written by: J. Smith |
Hits: 953
|
|
Controversial Super Bowl Ad Sparks Debate Over Compounded GLP-1 Medications
|
Written by: J. Smith |
Hits: 1016
|
|
Novo Nordisk's CagriSema Gains Momentum Amid Investor Optimism and Legal Scrutiny
|
Written by: J. Smith |
Hits: 1093
|
|
FDA Approves Ozempic for Chronic Kidney Disease in Type 2 Diabetes
|
Written by: J. Smith |
Hits: 914
|
|
Novo Nordisk's Amycretin Shows 22% Weight Loss in Early Trial Results
|
Written by: J. Smith |
Hits: 1037
|
|
Novo Nordisk and Valo Health Expand AI-Powered Partnership to Address Cardiometabolic Diseases
|
Written by: J. Smith |
Hits: 824
|
|
Semaglutide 7.2 mg Demonstrates Greater Weight Loss but Faces Market Challenges
|
Written by: J. Smith |
Hits: 757
|
|
2025 Outlook: GLP-1 Supply Gains Momentum Amid Expansion Efforts
|
Written by: J. Smith |
Hits: 5361
|
|
Abbott and Dexcom Settle Global Patent Disputes Over CGM Technologies
|
Written by: J. Smith |
Hits: 1218
|
